Myocarditis and Pericarditis After COVID-19 mRNA Vaccination: Practical Considerations for Care Providers
Adriana Luk(Mount Sinai Hospital), Michael McDonald(University Health Network), Andrew D. Krahn(University of British Columbia), Anique Ducharme(Montreal Heart Institute), Brian W. McCrindle(University of Toronto), Monika Naus(University of British Columbia), Brian Clarke(MedStar Washington Hospital Center), Shelley Zieroth(University of Manitoba), Jacob A. Udell(University Health Network), Trent Mizzi(University of Toronto), Sean Virani(University of British Columbia), Nagib Dahdah(Centre Hospitalier Universitaire Sainte-Justine)
Cited by 66
Related Papers
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
|Circulation|2017|3.7k
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
|New England Journal of Medicine|2008|1.6k
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure
|European Journal of Heart Failure|2021|1.5k
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
The Agenda for Familial Hypercholesterolemia
|Circulation|2015|726